Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SEEVIX Phase-1

Financiado

Cerrado

Spidersilk fibers as scaffold for tissue engineering skin regeneratin and wound...

Spidersilk fibers as scaffold for tissue engineering skin regeneratin and wound healing Silk from silkworms has been used by man for thousands of years. Spiders, however, are territorial and not subject to domestication. Consequently, their silk, which is much stronger than that of silkworms, cannot be grown in comme... ver más

31/08/2018

Seevix

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

SEEVIX MATERIAL SCIENCES LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-08-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Seevix

50.00K€ | Lider

TRIMEK

541.65K€ | Participante

Proyectos interesantes

MAT2016-75544-C2-1-R

Medical Technol...

Materials Scien...

48K€ Cerrado

MAT2016-75544-C2-2-R

Medical Technol...

Materials Scien...

48K€ Cerrado

CNS2023-145568

Medical Technol...

Materials Scien...

200K€ Cerrado

MAT2012-38359-C03-01

Medical Technol...

Materials Scien...

82K€ Cerrado

DPI2009-07514

Medical Technol...

Materials Scien...

136K€ Cerrado

MAT2012-38412-C02-01

Medical Technol...

Materials Scien...

47K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 3 meses Fecha Inicio: 2018-05-09
Fecha Fin: 2018-08-31

Líder del proyecto

SEEVIX MATERIAL SCIENCES LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Silk from silkworms has been used by man for thousands of years. Spiders, however, are territorial and not subject to domestication. Consequently, their silk, which is much stronger than that of silkworms, cannot be grown in commercial quantities. To overcome this problem, scientists have attempted to create synthetic spidersilk through genetic engineering of its proteins by means of bacteria, yeast, plants, mammalian cells in tissue culture, and even transgenic goats, but fibers resulting from these efforts have proven dissimilar or inferior to natural spidersilk. Seevix has overcome the technology barrier and produces fibers identical to the fibers in nature. Seevix’s fibers can be used as scaffolds for tissue engineering and wound closure, and can support true 3D cell growth. Seevix spidersilk fibers improve the viability, function and overall health of cell culture at several levels. Our fibers conserve cell function over time, delay cell death and maintain spheroid integrity even during prolonged culturing. These effects were demonstrated in primary cell lines used in drug and toxicity screenings, as well as in proliferating cell lines. Seevix expects to introduce its first revenue generating 3D cell culture product into the market in 2018. The Phase-1 is an excellent instrument to accelerate the risk analysis and define a suitable strategy to boost the market introduction of Seevix fibers at international level, bringing key conclusions for the company about the target segments, market size and internal operational and financial needs to successfully deploy a strategic growth plan to take advantage of the huge market opportunity.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores